FIBROPLANT

Pharmaceutical preparations, namely, levonorgestrel with a controlled release membrane for use in contraception, endometrial suppression in perimenopausal and postmenopausal women using hormone replacement therapy, idiopathic menorrhagia, and other reproductive endocrine disorders and diseases; Medical devices, namely, intrauterine devices and systems, namely, a fiber containing levonorgestrel with a controlled release membrane affixed to a length of suture material and parts therefore